Dr Dillon on Considerations for GLP-1s in the Neuroendocrine Tumor Space Sabrina Serani , Kelly King GLP-1 receptor agonists show promise in treating various chronic conditions, but potential risks and unanswered questions remain for care of patients with NETs
For commercial plan sponsors, pharmacy benefit spending grew by 4.0%
Showing some of the highest readings in both the heel (113 SA) and the forefoot (93 SA), this is our ultimate low-top basketball shoe with the best shock absorption
The Science Behind Naturecans Formulas Every product in our GLP-1 range is backed by clinical data, formulated by experts, and third-party tested for purity
80% of patients at that point were still on the drug, a self-described impressive retention rate suggesting very good tolerability
While both support metabolic health and appetite regulation, they work slightly differently